Vallinga Marleen S, Roijer Philippine J, Pidgeon Thomas E, Angelini Matteo, Ceulemans Aline, Bakker Alex, Carrière Brenda, Rashid Tina, Bellringer James, Belinky Javier, Buncamper Marlon, Morrison Shane D, Bouman Walter P, van de Grift Tim C, Bouman Mark-Bram, Mullender Margriet G
Department of Plastic, Reconstructive and Hand Surgery, Amsterdam UMC (Location VUmc) - Amsterdam University Medical Centre, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
EClinicalMedicine. 2025 Jul 1;85:103323. doi: 10.1016/j.eclinm.2025.103323. eCollection 2025 Jul.
Feminizing genital gender-affirming surgery (gGAS) comprises various surgical procedures and techniques. Comprehensive knowledge of the outcomes of all procedures and techniques is fundamental for informed decision-making. However, in current research on feminizing gGAS there is significant heterogeneity in reported outcomes. Standardization of outcome measurement is therefore urgently required. This study aimed to develop a Core Outcome Set (COS) for feminizing gGAS.
A multidisciplinary, international study steering group comprising 16 panellists from Europe, the United Kingdom, North America, and South America-including health care professionals and transgender individuals-was appointed to guide the development of a COS. The steering group convened on 16 June 2022, 28 September 2023, 2 May 2024, and 29 August 2024. The study involved three phases: (i) relevant outcomes were identified through a literature review and focus groups with transgender and gender-diverse people; (ii) stakeholders were invited to participate in an international Delphi study to reach consensus on the key outcomes; (iii) a consensus meeting was held to reach a final consensus on the COS.
Initial data collection yielded 2621 unique outcomes. This number was reduced to 39 potential outcomes for the Delphi process through a structured selection process. The Delphi rounds encompassed February, May and July 2024 respectively. Following the consensus meeting in September 2024, a final list of 11 outcomes was agreed, of which six are patient-reported outcomes. Seven outcomes apply to all feminizing gGAS procedures and four are specific to vaginoplasty procedures involving the creation of a vaginal canal.
Adoption of the COS for feminizing gGAS could ensure that the most relevant outcomes in clinical research are measured and reported in a standardized way. Future studies adopting these suggested outcome measures could reduce the heterogeneity of reported outcomes across studies and working to improve the quality of research and care.
None received.
女性化生殖器性别确认手术(gGAS)包含多种外科手术程序和技术。全面了解所有程序和技术的结果是做出明智决策的基础。然而,在当前关于女性化gGAS的研究中,报告的结果存在显著异质性。因此,迫切需要对结果测量进行标准化。本研究旨在制定女性化gGAS的核心结局集(COS)。
一个多学科的国际研究指导小组由来自欧洲、英国、北美和南美的16名小组成员组成,包括医疗保健专业人员和跨性别者,被任命来指导COS的制定。指导小组于2022年6月16日、2023年9月28日、2024年5月2日和2024年8月29日召开会议。该研究包括三个阶段:(i)通过文献综述以及与跨性别和性别多样化人群的焦点小组确定相关结局;(ii)邀请利益相关者参与国际德尔菲研究,就关键结局达成共识;(iii)召开共识会议,就COS达成最终共识。
初步数据收集产生了2621个独特的结局。通过结构化选择过程,这个数字在德尔菲过程中减少到39个潜在结局。德尔菲轮次分别涵盖2024年2月、5月和7月。在2024年9月的共识会议之后,商定了一份包含11个结局的最终清单,其中6个是患者报告的结局。7个结局适用于所有女性化gGAS手术,4个结局特定于涉及创建阴道管的阴道成形术手术。
采用女性化gGAS的COS可以确保临床研究中最相关的结局以标准化方式进行测量和报告。采用这些建议的结局测量方法的未来研究可以减少各研究报告结局的异质性,并致力于提高研究和护理质量。
未获得任何资金。